How Much Did Clinomic Raise?
Funding & Key Investors

Clinomic, the Aachen-based MedTech innovator, has successfully secured a major strategic investment, bringing its total capital accumulation to $25.6M. This latest infusion of $25.6M underscores the market's confidence in the company's proprietary AI-driven platform, Mona, which is currently redefining the standards of intensive care medicine. By integrating complex patient data management with real-time clinical decision support, Clinomic is positioning itself as a critical infrastructure provider within the European healthcare landscape.

What is Clinomic?

Clinomic
SoftwareHealthcare SoftwareBusiness Services

Founded in 2019, Clinomic has evolved from a specialized software developer into a comprehensive digital health group. The company's flagship solution, Mona, serves as a centralized hub for critical care, effectively bridging the gap between raw clinical data and actionable medical insights. Through its expansion into the Clinomic Group, the firm now addresses the broader spectrum of hospital digital transformation, including telemedicine and advanced data analytics. This multi-faceted approach allows Clinomic to optimize hospital workflows while simultaneously improving patient outcomes in high-acuity environments, a sector historically resistant to rapid technological adoption.

How much funding has Clinomic raised?

Clinomic has raised a total of $25.6M across 1 funding round:

2025

Series B

$25.6M

Series B (2025): $25.6M with participation from DeepTech & Climate Fonds

Key Investors in Clinomic

DeepTech & Climate Fonds

DeepTech & Climate Fonds is a prominent venture capital entity managing 1 billion EUR, dedicated to supporting early growth ventures that develop transformative technologies within the German and European markets.

What's next for Clinomic?

With this major enterprise-level funding, Clinomic is poised to accelerate its international scaling efforts and deepen its R&D capabilities in predictive clinical analytics. The strategic focus will likely shift toward expanding the footprint of the Clinomic Group across European hospital networks, leveraging the recent capital to enhance the interoperability of the Mona platform. As the company matures, the emphasis will remain on navigating the complex regulatory requirements of the MedTech sector while maintaining its competitive edge in AI-assisted critical care. Future growth will be defined by the firm's ability to integrate its digital transformation services into existing hospital infrastructures, thereby cementing its role as an indispensable partner in modern healthcare delivery.

See full Clinomic company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Software industry

Business Intelligence (BI) SoftwareSoftware
Healthcare SoftwareSoftwareBusiness Intelligence (BI) Software
Content & Collaboration SoftwareSoftwareStorage & System Management Software
Enterprise Resource Planning (ERP)SoftwareContent & Collaboration Software

Frequently Asked Questions Regarding Clinomic Financial Insights

What are the most recent funding rounds that Clinomic has completed, and what were the funding rounds?
Clinomic has recently completed 1 funding rounds: Series B on Apr 14, 2025.
What is the total amount of funding Clinomic has raised to date?
Clinomic has raised a total of $25.6M in funding to date.
How many funding rounds has Clinomic completed?
Clinomic has completed 1 funding rounds.
How much funding did Clinomic raise in its most recent funding round?
Clinomic raised $25.6M in its most recent funding round.
Who are the lead investors in Clinomic's latest funding round?
The lead investor in Clinomic's latest funding round was DeepTech & Climate Fonds. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Clinomic's history?
The largest funding round in Clinomic's history was $25.6M.
See more information about Clinomic